Skip to content

Scholar Rock SRRK Free cash flow yield

Free cash flow yield at other companies

Biogen logo
BiogenBIIB
9%-3.2pp
PTC Therapeutics logo
PTC TherapeuticsPTCT
17.2%+14.6pp
Travere Therapeutics, Inc. logo
Travere Therapeutics, Inc.TVTX
-25.1%-6.6pp
Cogent Biosciences, Inc. logo
Cogent Biosciences, Inc.COGT
-4.6%-2.1pp
BridgeBio Pharma logo
BridgeBio PharmaBBIO
-3.1%
Arrowhead Research logo
Arrowhead ResearchARWR
0.5%+0.3pp

Other financials

Income statement

See full
Revenue-
Operating income-$102.0M-32.3%
Net income-$105.5M-41.2%
EPS (diluted)-$0.83-23.9%

Balance sheet

See full
Cash & equivalents$430.5M+212%
Total debt$205.7M+226%
Total equity$276.0M-11.6%
Total assets$535.3M+31.3%

Cash flow

See full
Operating cash flow-$82.1M-4.4%
CapEx$68.0K-74.9%
Free cash flow-$82.2M-4.1%

Valuation

See full
Market cap$5.67B+85.5%
Enterprise value$5.45B+82.6%
P/S170.9×

Profitability

See full
Operating margin-231.8%
Net margin-236.9%
FCF margin-309.1%

Returns & leverage

See full
Return on equity-138.9%+60.1pp
Debt / equity0.7×+0.5×
Current ratio8.6×-1.6×

Where this comes from

Calculated from Scholar Rock’s reported figures.

Based on trailing twelve months.

The official record: Scholar Rock’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Scholar Rock's free cash flow yield.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Scholar Rock's free cash flow yield?
Scholar Rock (SRRK) reported free cash flow yield of -5.4% in Q1 2026.
How has Scholar Rock's free cash flow yield changed year-over-year?
Scholar Rock's free cash flow yield increased by 28.9% year-over-year, from -7.6% to -5.4%.
What is the long-term trend for Scholar Rock's free cash flow yield?
Over 5 years (2020 to 2025), Scholar Rock's free cash flow yield has grown at a 12.1% compound annual growth rate (CAGR), from -3.8% to -6.7%.
What does free cash flow yield mean?
Trailing-twelve-month free cash flow divided by market capitalization at the quarter end. The cash return the business generates relative to its market price.